These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 11447388)

  • 1. Preclinical evaluation of an immunotherapeutic peptide comprising 7 T-cell determinants of Cry j 1 and Cry j 2, the major Japanese cedar pollen allergens.
    Hirahara K; Tatsuta T; Takatori T; Ohtsuki M; Kirinaka H; Kawaguchi J; Serizawa N; Taniguchi Y; Saito S; Sakaguchi M; Inouye S; Shiraishi A
    J Allergy Clin Immunol; 2001 Jul; 108(1):94-100. PubMed ID: 11447388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell epitopes in Japanese cedar (Cryptomeria japonica) pollen allergens: choice of major T cell epitopes in Cry j 1 and Cry j 2 toward design of the peptide-based immunotherapeutics for the management of Japanese cedar pollinosis.
    Sone T; Morikubo K; Miyahara M; Komiyama N; Shimizu K; Tsunoo H; Kino K
    J Immunol; 1998 Jul; 161(1):448-57. PubMed ID: 9647255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of helper T cell responses to Cry j 1-derived peptides in patients with nasal allergy: candidate for peptide-based immunotherapy of Japanese cedar pollinosis.
    Masuyama K; Chikamatsu K; Ikagawa S; Matsuoka T; Takahashi G; Yamamoto T; Endo S
    Allergol Int; 2009 Mar; 58(1):63-70. PubMed ID: 19050376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of human T cell epitopes in Japanese cypress pollen allergen, Cha o 1, elucidates the intrinsic mechanism of cross-allergenicity between Cha o 1 and Cry j 1, the major allergen of Japanese cedar pollen, at the T cell level.
    Sone T; Dairiki K; Morikubo K; Shimizu K; Tsunoo H; Mori T; Kino K
    Clin Exp Allergy; 2005 May; 35(5):664-71. PubMed ID: 15898991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of carbohydrates on Cry j 1, the major allergen of Japanese cedar pollen, in specific T-cell responses.
    Okano M; Kino K; Takishita T; Hattori H; Ogawa T; Yoshino T; Yokoyama M; Nishizaki K
    J Allergy Clin Immunol; 2001 Jul; 108(1):101-8. PubMed ID: 11447389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition of T cell epitopes unique to Cha o 2, the major allergen in Japanese cypress pollen, in allergic patients cross-reactive to Japanese cedar and Japanese cypress pollen.
    Sone T; Dairiki K; Morikubo K; Shimizu K; Tsunoo H; Mori T; Kino K
    Allergol Int; 2009 Jun; 58(2):237-45. PubMed ID: 19307778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide immunotherapy for allergic diseases using a rice-based edible vaccine.
    Hiroi T; Takaiwa F
    Curr Opin Allergy Clin Immunol; 2006 Dec; 6(6):455-60. PubMed ID: 17088651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological assay using T cell response for Cry-consensus peptide designed for the peptide-based immunotherapy of Japanese cedar pollinosis.
    Kozutsumi D; Tsunematsu M; Yamaji T; Kino K
    J Pharmacol Toxicol Methods; 2007; 55(3):297-302. PubMed ID: 16996752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of peptides containing T-cell epitopes of Japanese cedar (Cryptomeria japonica) pollen allergen (Cry j 1) in dogs.
    Masuda K; Sakaguchi M; Saito S; Yasueda H; Iwabuchi S; Tsukui T; Hayashi N; Nakao Y; Kurata K; Maeda S; Ohno K; Tsujimoto H
    Vet Immunol Immunopathol; 2004 Nov; 102(1-2):45-52. PubMed ID: 15451614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Cry-consensus peptide, a novel recombinant peptide for immunotherapy of Japanese cedar pollinosis, on an experimental allergic rhinitis model in B10.S mice.
    Tsunematsu M; Yamaji T; Kozutsumi D; Murakami R; Kimura S; Kino K
    Allergol Int; 2007 Dec; 56(4):465-72. PubMed ID: 17965586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA vaccination against Japanese cedar pollinosis in dogs suppresses type I hypersensitivity by controlling lesional mast cells.
    Masuda K
    Vet Immunol Immunopathol; 2005 Oct; 108(1-2):185-7. PubMed ID: 16098609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PS80 interferes with the antiallergic effect of Cry-consensus peptide, a novel recombinant peptide for immunotherapy of Japanese cedar pollinosis, at very low concentration through modulation of Th1/Th2 balance.
    Kozutsumi D; Tsunematsu M; Yamaji T; Murakami R; Yokoyama M; Kino K
    Immunology; 2006 Jul; 118(3):392-401. PubMed ID: 16827900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant Fusion Allergens, Cry j 1 and Cry j 2 from Japanese Cedar Pollen, Conjugated with Polyethylene Glycol Potentiate the Attenuation of Cry j 1-Specific IgE Production in Cry j 1-Sensitized Mice and Japanese Cedar Pollen Allergen-Sensitized Monkeys.
    Fujimura T; Fujinami K; Ishikawa R; Tateno M; Tahara Y; Okumura Y; Ohta H; Miyazaki H; Taniguchi M
    Int Arch Allergy Immunol; 2015; 168(1):32-43. PubMed ID: 26524293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of major oligosaccharides on Cry j 1 in human immunoglobulin E and T cell responses.
    Okano M; Kimura Y; Kino K; Michigami Y; Sakamoto S; Sugata Y; Maeda M; Matsuda F; Kimura M; Ogawa T; Nishizaki K
    Clin Exp Allergy; 2004 May; 34(5):770-8. PubMed ID: 15144470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled trial of sublingual immunotherapy for Japanese cedar pollinosis.
    Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Yamamoto H; Kunii N; Sakurai D; Fujimura T; Nakazawa K; Yasueda H
    Int Arch Allergy Immunol; 2008; 146(1):76-84. PubMed ID: 18087165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular immunology of Japanese cedar pollen allergens: analysis of T cell epitopes].
    Hashiguchi S; Sugimura K
    Nihon Rinsho; 1996 Aug; 54(8):2233-42. PubMed ID: 8810803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cry j 1-induced synthesis of interleukin-5 and interferon-gamma by peripheral blood mononuclear cells of patients with seasonal allergic rhinitis due to Japanese cedar pollens.
    Nakai Y; Ohashi Y; Tanaka A; Kakinoki Y; Washio Y; Masamoto T; Yamada K; Nakai Y; Ohmoto Y
    Acta Otolaryngol Suppl; 1998; 538():143-51. PubMed ID: 9879414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetically engineered hybrid proteins from Parietaria judaica pollen for allergen-specific immunotherapy.
    González-Rioja R; Ibarrola I; Arilla MC; Ferrer A; Mir A; Andreu C; Martínez A; Asturias JA
    J Allergy Clin Immunol; 2007 Sep; 120(3):602-9. PubMed ID: 17561242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 26-Week oral safety study in macaques for transgenic rice containing major human T-cell epitope peptides from Japanese cedar pollen allergens.
    Domon E; Takagi H; Hirose S; Sugita K; Kasahara S; Ebinuma H; Takaiwa F
    J Agric Food Chem; 2009 Jun; 57(12):5633-8. PubMed ID: 19462978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell activation by transgenic rice seeds expressing the genetically modified Japanese cedar pollen allergens.
    Takaishi S; Saito S; Endo T; Asaka D; Wakasa Y; Takagi H; Ozawa K; Takaiwa F; Otori N; Kojima H
    Immunology; 2019 Oct; 158(2):94-103. PubMed ID: 31323138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.